SOHO 2022 Tenth Annual Meeting

 

SOHO 2022 Tenth Annual Meeting
J

SOHO 2022: Cost-Effectiveness of Polatuzumab Vedotin in Previously Untreated DLBCL

By SOHO 2022 Tenth Annual Meeting FEATURING John Burke
By SOHO 2022 Tenth Annual Meeting FEATURING John Burke
27 views
October 14, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Lymphoma
10:00

SOHO 2022: Biology and Treatment of LGL Leukemia

SOHO 2022 Tenth Annual Meeting

T. Loughran

166 views
10:35

SOHO 2022 Next Questions: Hodgkin Lymphoma

SOHO 2022 Tenth Annual Meeting

N. Bartlett

239 views
10:19

Next Questions: Mantle Cell Lymphoma

SOHO 2022 Tenth Annual Meeting

K. Maddocks

71 views
11:27

SOHO 2022 Next Questions: T-Cell Lymphoma

SOHO 2022 Tenth Annual Meeting

S. Iyer

44 views
12:37

SOHO 2022 Next Questions: Follicular Lymphoma

SOHO 2022 Tenth Annual Meeting

G. Salles

79 views
15:31

SOHO 2022: What's Next in Aggressive B-Cell Lymphoma?

SOHO 2022 Tenth Annual Meeting

L. Sehn

456 views
10:34

SOHO 2022 Next Questions: Cellular Therapy

SOHO 2022 Tenth Annual Meeting

K. Komanduri

190 views
16:19

SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro AUTO H…

SOHO 2022 Tenth Annual Meeting

C. Sauter

29 views
12:05

SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro CAR T-…

SOHO 2022 Tenth Annual Meeting

M. Kamdar

49 views
08:34

SOHO 2022: Camidanlumab Tesirine - Updated Efficacy and Safety in Pa…

SOHO 2022 Tenth Annual Meeting

A. Herrera

27 views
16:42

SOHO 2022: Treating Hodgkin Lymphoma After Brentuximab Vedotin and A…

SOHO 2022 Tenth Annual Meeting

A. Herrera

147 views
16:18

SOHO 2022: Sequencing Novel Agents in Frontline and Second-Line Trea…

SOHO 2022 Tenth Annual Meeting

A. Moskowitz

235 views
07:04

Phase 1/2 BRUIN Study - Updated Results on Pirtobrutinib in Previous…

SOHO 2022 Tenth Annual Meeting

J. Cohen

118 views
19:47

Emerging Treatment Options for MCL

SOHO 2022 Tenth Annual Meeting

J. Ruan

57 views
13:18

Immunotherapeutic Options for Patients With MCL Who Progress on BTK …

SOHO 2022 Tenth Annual Meeting

J. Cohen

80 views
14:31

The Role of Targeted Therapies in Frontline Treatment of MCL

Tycel Phillips

127 views
16:52

Is it Time to Recognize the Biological Heterogeneity of MCL?

SOHO 2022 Tenth Annual Meeting

A. Goy

82 views
08:47

SOHO 2022: Cost-Effectiveness of Polatuzumab Vedotin in Previously U…

SOHO 2022 Tenth Annual Meeting

J. Burke

27 views
08:56

SOHO 2022: Results from POLARIX, a Phase III Study of Pola-R-CHP vs.…

SOHO 2022 Tenth Annual Meeting

C. Flowers

274 views
13:55

SOHO 2022: Managing the Elderly Patient With Aggressive B-cell Lymph…

SOHO 2022 Tenth Annual Meeting

C. Thieblemont

29 views
11:32

SOHO 2022: CNS Prophylaxis in DLBCL

SOHO 2022 Tenth Annual Meeting

V. Orellana-Noia

52 views
14:57

SOHO 2022: Treatment of Aggressive B-cell Lymphoma Post-CAR T-Cell T…

SOHO 2022 Tenth Annual Meeting

G. Nowakowski

25 views
15:19

SOHO 2022: The Emerging Potential of Bispecific Antibodies as Monoth…

SOHO 2022 Tenth Annual Meeting

M. Dickinson

111 views
15:03

SOHO 2022: Choosing CAR T-Cell Therapy vs. ASCT in R/R Aggressive B-…

SOHO 2022 Tenth Annual Meeting

M. Kamdar

158 views
15:33

SOHO 2022: Has R-CHOP Really Been Replaced as Initial Therapy of DLB…

SOHO 2022 Tenth Annual Meeting

J. Friedberg

994 views
05:56

SOHO 2022: Pivotal Results From a Phase I/II Study of Mosunetuzumab …

SOHO 2022 Tenth Annual Meeting

L. Nastoupil

40 views
19:37

SOHO 2022: Using Biology to Determine Type and Duration of Treatment…

SOHO 2022 Tenth Annual Meeting

P. Kapoor

18 views
15:04

SOHO 2022: Future Role of Bispecific Antibodies in the Treatment of …

SOHO 2022 Tenth Annual Meeting

E. Budde

32 views
15:37

SOHO 2022: What Is the Role of Transplantation for FL in the Era of …

SOHO 2022 Tenth Annual Meeting

M. Hamadani

20 views
15:08

SOHO 2022: Sequencing Therapy in Indolent Lymphoma - Treatment Choic…

SOHO 2022 Tenth Annual Meeting

L. Nastoupil

276 views
10:04

SOHO 2022: Correlation of TRBC1 by Flow Cytometry With Molecular T-C…

SOHO 2022 Tenth Annual Meeting

T. Dexter

15 views
14:13

SOHO 2022: Advances in the Treatment of NK/T Cell Lymphoma

SOHO 2022 Tenth Annual Meeting

W. Kim

30 views
16:35

SOHO 2022: Integrating Novel Agents Into the Management of Cutaneous…

SOHO 2022 Tenth Annual Meeting

P. Allen

76 views
15:40

SOHO 2022: Novel Treatment Approaches in Relapsed/Refractory PTCL

SOHO 2022 Tenth Annual Meeting

M. Lunning

14 views
15:49

SOHO 2022: The Next Rational Therapeutic Regimen in Newly Diagnosed …

SOHO 2022 Tenth Annual Meeting

N. Mehta-Shah

28 views
14:21

SOHO 2022: From Bench to Bedside - A Translational Scientist's Persp…

SOHO 2022 Tenth Annual Meeting

F. Vega

20 views
21:46

SOHO 2022: CAR T-Cells in Indolent B-Cell Lymphomas

SOHO 2022 Tenth Annual Meeting

J. Abramson

87 views
18:24

SOHO 2022: Challenging Cases in Rare T-Cell Lymphomas

SOHO 2022 Tenth Annual Meeting

S. Barta

22 views
11:16

SOHO 2022: Basis for Targeting the Microenvironment in Hodgkin Lymph…

SOHO 2022 Tenth Annual Meeting

C. Steidl

78 views
11:27

SOHO 2022: CAR T-Cell Therapy in Hodgkin Lymphoma

SOHO 2022 Tenth Annual Meeting

C. Ramos

22 views
13:22

SOHO 2022: The Next Generation of Novel Agents in Development for Ag…

SOHO 2022 Tenth Annual Meeting

J. Westin

238 views